The Vanderbilt-Ingram Cancer Center is set to host a significant educational event titled “The Future of Lung Cancer Care” on May 8, 2024. This one-day conference will take place at the Nashville Marriott at Vanderbilt University from 8:30 a.m. to 2:30 p.m.. The focus will be on the latest advancements in lung cancer treatment, particularly improvements in patient outcomes and survival rates stemming from early detection and innovative therapies.
Recent findings from the American Lung Association highlight that the five-year survival rate for lung cancer patients has nearly doubled over the past decade, a testament to the effectiveness of advanced imaging, minimally invasive procedures, and breakthroughs in targeted and immune-based therapies. The conference aims to disseminate this information to a broader audience, including families, caregivers, clinicians, and trainees interested in lung cancer management.
Expert Speakers and Key Discussion Topics
The event will feature a lineup of esteemed experts in the field. Daniel Sterman, MD, who directs the Multidisciplinary Pulmonary Oncology Program at New York University Langone Health, will present on “Interventional Pulmonology: Bronchoscopically Delivered Treatment of Early Lung Cancer.” His insights will provide valuable information on how bronchoscopic techniques are transforming early-stage lung cancer treatment.
Another prominent speaker, Mohamed Shanshal, MBChB, an assistant professor of Medicine at Vanderbilt Health, will address the integration of immunotherapy and targeted therapy in his session titled “Medical Oncology: Integrating Immunotherapy, Targeted Therapy, and Beyond.” This discussion is crucial as it explores the evolving landscape of lung cancer treatment options.
Additionally, Joseph Mammarappallil, MD, PhD, an associate professor of Radiology at Duke University School of Medicine, will share insights on “Interventional Radiology: Imaging-Driven Precision and Local Control.” His presentation will highlight the role of advanced imaging techniques in improving treatment precision.
Several other experts from Vanderbilt Health will also contribute to discussions on topics such as advances in early detection, minimally invasive biopsy techniques, and the expanding role of survivorship care and supportive services.
Continuing Medical Education and Registration
The conference not only aims to educate attendees but also provides opportunities for professional development. Physicians who participate will be eligible to claim 7.0 AMA PRA Category 1 credits towards their continuing medical education requirements.
Reservations for the conference can be made through Eventbrite, and the event welcomes anyone interested in advancing their knowledge of lung cancer care. This is a unique opportunity for individuals to engage with leading experts and stay informed about the latest advancements in the field.
In summary, “The Future of Lung Cancer Care” conference is expected to be a pivotal event for anyone involved in lung cancer management, reflecting the ongoing commitment to improving patient outcomes through education and collaboration.
